US 8324155
Quinoxaline-containing compounds as hepatitis C virus inhibitors
granted A61PA61P31/12A61P31/14
Quick answer
US patent 8324155 (Quinoxaline-containing compounds as hepatitis C virus inhibitors) held by Enanta Pharmaceuticals, Inc. expires Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Dec 04 2012 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Nov 29 2032 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 29
- CPC classes
- A61P, A61P31/12, A61P31/14, A61P43/00